Trupanion (NASDAQ:TRUP – Get Rating) is one of 13 publicly-traded companies in the “Hospital & medical service plans” industry, but how does it contrast to its competitors? We will compare Trupanion to similar companies based on the strength of its earnings, profitability, institutional ownership, analyst recommendations, dividends, valuation and risk.
Institutional and Insider Ownership
83.5% of Trupanion shares are held by institutional investors. Comparatively, 88.0% of shares of all “Hospital & medical service plans” companies are held by institutional investors. 6.8% of Trupanion shares are held by insiders. Comparatively, 1.5% of shares of all “Hospital & medical service plans” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
This is a breakdown of recent ratings for Trupanion and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Trupanion currently has a consensus price target of $133.50, indicating a potential upside of 55.21%. As a group, “Hospital & medical service plans” companies have a potential upside of 1.02%. Given Trupanion’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Trupanion is more favorable than its competitors.
Earnings & Valuation
This table compares Trupanion and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Trupanion||$698.99 million||-$35.53 million||-97.74|
|Trupanion Competitors||$71.33 billion||$2.57 billion||5.84|
Trupanion’s competitors have higher revenue and earnings than Trupanion. Trupanion is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This table compares Trupanion and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Trupanion has a beta of 2.06, suggesting that its share price is 106% more volatile than the S&P 500. Comparatively, Trupanion’s competitors have a beta of 1.04, suggesting that their average share price is 4% more volatile than the S&P 500.
Trupanion competitors beat Trupanion on 7 of the 13 factors compared.
About Trupanion (Get Rating)
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.